Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002515846 | SCV001633248 | likely benign | Rubinstein-Taybi syndrome due to EP300 haploinsufficiency | 2024-11-05 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001572184 | SCV001796782 | likely benign | not provided | 2021-01-11 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001572184 | SCV004153138 | likely benign | not provided | 2024-04-01 | criteria provided, single submitter | clinical testing | EP300: BP4, BS2 |
ITMI | RCV000120721 | SCV000084884 | not provided | not specified | 2013-09-19 | no assertion provided | reference population | |
Prevention |
RCV003935151 | SCV004750227 | likely benign | EP300-related disorder | 2021-10-25 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |